DE60012836D1 - Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis - Google Patents

Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis

Info

Publication number
DE60012836D1
DE60012836D1 DE60012836T DE60012836T DE60012836D1 DE 60012836 D1 DE60012836 D1 DE 60012836D1 DE 60012836 T DE60012836 T DE 60012836T DE 60012836 T DE60012836 T DE 60012836T DE 60012836 D1 DE60012836 D1 DE 60012836D1
Authority
DE
Germany
Prior art keywords
simethicone
ulcerative colitis
treat ulcerative
treat
colitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60012836T
Other languages
English (en)
Other versions
DE60012836T2 (de
Inventor
Thomas Sox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of DE60012836D1 publication Critical patent/DE60012836D1/de
Publication of DE60012836T2 publication Critical patent/DE60012836T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60012836T 1999-09-07 2000-05-30 Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis Expired - Fee Related DE60012836T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/390,812 US6100245A (en) 1999-09-07 1999-09-07 Use of simethicone to treat ulcerative colitis
US390812 1999-09-07

Publications (2)

Publication Number Publication Date
DE60012836D1 true DE60012836D1 (de) 2004-09-16
DE60012836T2 DE60012836T2 (de) 2005-09-01

Family

ID=23544040

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012836T Expired - Fee Related DE60012836T2 (de) 1999-09-07 2000-05-30 Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis

Country Status (12)

Country Link
US (1) US6100245A (de)
EP (1) EP1084706B1 (de)
JP (1) JP2001106630A (de)
KR (1) KR20010049495A (de)
CN (1) CN1156280C (de)
AR (1) AR024286A1 (de)
AT (1) ATE273013T1 (de)
BR (1) BR0002640A (de)
CA (1) CA2311035A1 (de)
DE (1) DE60012836T2 (de)
ES (1) ES2225027T3 (de)
MX (1) MXPA00005545A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
CN1297319C (zh) * 2003-09-22 2007-01-31 王玉万 以硅油为介质制备含抗微生物药物的制剂
AR053579A1 (es) * 2005-04-15 2007-05-09 Genentech Inc Tratamiento de la enfermedad inflamatoria intestinal (eii)
KR102648960B1 (ko) 2017-09-29 2024-03-20 존슨 앤드 존슨 컨수머 인코포레이티드 고체 시메티콘 입자 및 이의 투여 형태
US11986492B2 (en) * 2022-09-21 2024-05-21 Ashley Wolchina Allison Oral supplement for preventing colic in horses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE746827C (de) * 1938-12-24 1944-08-25 Louis Friedmann & Co Selbstregelung der Niederdruckdampfheizung in einem Fahrzeug, insbesondere Schienenfahrzeug
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
EP0406248B1 (de) * 1989-01-19 1994-06-08 Alfred Schmidt Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
AU674016B2 (en) * 1992-07-30 1996-12-05 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedy for inflammatory intestinal diseases
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5418220A (en) * 1994-03-08 1995-05-23 Schmidt; Alfred Method for treating constipation using dimethicone
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
AU706351B2 (en) * 1994-03-18 1999-06-17 Alfred Schmidt The use of dimeticone as a transport and carrier system and/or drug delivery system
DE4423915A1 (de) * 1994-07-07 1996-01-11 Carl Heinrich Dr Weischer Derivate des Salazosulfapyridins, deren Herstellung und Verwendung als Arzneimittel
US5846567A (en) * 1997-04-16 1998-12-08 Chek-Med Systems, Inc. Clot dissolving method

Also Published As

Publication number Publication date
MXPA00005545A (es) 2002-04-24
KR20010049495A (ko) 2001-06-15
ES2225027T3 (es) 2005-03-16
CN1156280C (zh) 2004-07-07
DE60012836T2 (de) 2005-09-01
BR0002640A (pt) 2001-06-12
JP2001106630A (ja) 2001-04-17
EP1084706B1 (de) 2004-08-11
CA2311035A1 (en) 2001-03-07
US6100245A (en) 2000-08-08
AR024286A1 (es) 2002-09-25
EP1084706A3 (de) 2002-07-17
ATE273013T1 (de) 2004-08-15
EP1084706A2 (de) 2001-03-21
CN1286978A (zh) 2001-03-14

Similar Documents

Publication Publication Date Title
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE69831134D1 (de) Behandlung von wasser
ATE260332T1 (de) Behandlung von textilien
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE257013T1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE338552T1 (de) Verwendungen von et743 zur behandlung von krebs
ATE353218T1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE266082T1 (de) Behandlung von substratoberfläche
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
DE60015516D1 (de) Verwendung von makroliden zur behandlung von trockenen augen
ATE339955T1 (de) Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE390474T1 (de) Verwendung von polymerem material zur behandlung harter oberflächen
ATE410181T1 (de) Verwendung von intereferon gamma zur behandlung von herzhypertrophie
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE326969T1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60012836D1 (de) Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis
DE60026821D1 (de) Behandlung von bohrspülung
DE60103685D1 (de) Behandlung von Poriomania
DE60110748D1 (de) Behandlung von fluorkohlenstoff-beschickungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee